Litcius/Paper detail

KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results

Andreas Maetzel, Michael D. Smith, Edward J. Duckworth, Sally L. Hampton, Gian Marco De Donatis, Nivetha Murugesan, Louise J. Rushbrooke, Lily Li, Danielle Francombe, Edward P. Feener, Christopher Yea

2022Journal of Allergy and Clinical Immunology20 citationsDOI

Topics & Concepts

TolerabilityMedicineHereditary angioedemaPharmacokineticsPharmacodynamicsCrossover studyCoefficient of variationAngioedemaDosingBradykininAdverse effectPlaceboPharmacologyInternal medicineChemistryImmunologyChromatographyAlternative medicineReceptorPathologyCoagulation, Bradykinin, Polyphosphates, and AngioedemaComplement system in diseasesHemophilia Treatment and Research
KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results | Litcius